As the hair supplements market is projected to reach over $2.86 billion by 2031, there’s a growing shift towards organic and clean-label solutions. Valensa’s CEO, Umasudhan Palaniswamy, has personal experience with the challenges of hair loss. He found that traditional supplements like biotin and pharmaceutical options were not effective or desirable. This led to the development of USPlus® DERM, a breakthrough product utilizing a patent-pending, ultra-high pressure supercritical CO2 process to concentrate key bioactive fatty acids essential for hair follicle health.
USPlus® DERM is built on the foundation of USPlus®, initially used for prostate health, and is now proving its efficacy in promoting hair growth and maintaining hair health. Scientific studies have shown that USPlus® DERM helps maintain the hair in its growth phase and supports the differentiation of keratin-producing cells, which are crucial for hair strength and vitality.
This innovative approach addresses not only male pattern hair loss but also the hair thinning concerns faced by women, especially after hormonal changes such as pregnancy. Valensa is committed to further research to optimize the effectiveness of USPlus® DERM for both men and women, aiming to provide a scientifically backed, natural solution for those seeking to improve their hair health.
For more detailed insights, please visit the featured article on NutraIngredients USA.
Click here for a more in-depth look at USPlus® DERM and how we’re redefining the standards of hair health.